Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Utility of glucose transporter 1 in the distinction of benign and malignant thoracic and abdominal mesothelial lesions.

Lagana SM, Taub RN, Borczuk AC.

Arch Pathol Lab Med. 2012 Jul;136(7):804-9. doi: 10.5858/arpa.2011-0219-OA.

PMID:
22742553
2.

The separation of benign and malignant mesothelial proliferations.

Churg A, Colby TV, Cagle P, Corson J, Gibbs AR, Gilks B, Grimes M, Hammar S, Roggli V, Travis WD.

Am J Surg Pathol. 2000 Sep;24(9):1183-200. Review.

PMID:
10976692
3.

Challenges and controversies in the diagnosis of mesothelioma: Part 1. Cytology-only diagnosis, biopsies, immunohistochemistry, discrimination between mesothelioma and reactive mesothelial hyperplasia, and biomarkers.

Henderson DW, Reid G, Kao SC, van Zandwijk N, Klebe S.

J Clin Pathol. 2013 Oct;66(10):847-53. doi: 10.1136/jclinpath-2012-201303. Epub 2013 Jun 27. Review.

PMID:
23814259
4.

Immunohistochemistry and molecular diagnostics of pleural malignant mesothelioma.

Betta PG, Magnani C, Bensi T, Trincheri NF, Orecchia S.

Arch Pathol Lab Med. 2012 Mar;136(3):253-61. doi: 10.5858/arpa.2010-0604-RA. Review.

PMID:
22372901
5.

Guidelines for pathologic diagnosis of malignant mesothelioma: 2012 update of the consensus statement from the International Mesothelioma Interest Group.

Husain AN, Colby T, Ordonez N, Krausz T, Attanoos R, Beasley MB, Borczuk AC, Butnor K, Cagle PT, Chirieac LR, Churg A, Dacic S, Fraire A, Galateau-Salle F, Gibbs A, Gown A, Hammar S, Litzky L, Marchevsky AM, Nicholson AG, Roggli V, Travis WD, Wick M; International Mesothelioma Interest Group.

Arch Pathol Lab Med. 2013 May;137(5):647-67. doi: 10.5858/arpa.2012-0214-OA. Epub 2012 Aug 28.

PMID:
22929121
7.

Pathology of malignant mesothelioma.

Van Marck E.

Lung Cancer. 2004 Aug;45 Suppl 1:S35-6. Review.

PMID:
15261431
8.

The diagnosis of thoracic malignant mesothelioma: practical considerations and recent developments.

Smith M, Colby T.

Turk Patoloji Derg. 2014;30(1):1-10. doi: 10.5146/tjpath.2013.01210. Review.

PMID:
24448702
9.

Malignant Mesothelioma Diagnosis.

Arif Q, Husain AN.

Arch Pathol Lab Med. 2015 Aug;139(8):978-80. doi: 10.5858/arpa.2013-0381-RA. Review.

PMID:
26230591
10.

The separation of benign and malignant mesothelial proliferations.

Churg A, Galateau-Salle F.

Arch Pathol Lab Med. 2012 Oct;136(10):1217-26. Review.

PMID:
23020727
11.

The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification.

Galateau-Salle F, Churg A, Roggli V, Travis WD; World Health Organization Committee for Tumors of the Pleura.

J Thorac Oncol. 2016 Feb;11(2):142-54. doi: 10.1016/j.jtho.2015.11.005. Review.

PMID:
26811225
12.

Diffuse malignant epithelioid mesothelioma in a background of benign multicystic peritoneal mesothelioma: a case report and review of the literature.

Mino JS, Monteiro R, Pigalarga R, Varghese S, Guisto L, Rezac C.

BMJ Case Rep. 2014 Feb 5;2014. pii: bcr2013200212. doi: 10.1136/bcr-2013-200212. Review.

13.

Benign and Malignant Mesothelial Proliferation.

Zeren EH, Demirag F.

Surg Pathol Clin. 2010 Mar;3(1):83-107. doi: 10.1016/j.path.2010.03.010. Epub 2010 Jul 7. Review.

PMID:
26839028
Items per page

Supplemental Content

Write to the Help Desk